Trump Administration Withholds Medicaid Funds From Minnesota Amid Fraud Claims
The Trump administration is currently withholding over $250 million in Medicaid funds from Minnesota, citing allegations of fraud within the state’s program. However, experts suggest that Minnesota’s fraud rates are significantly lower than the national average, raising questions about the administration’s motivations.
Medicaid, a joint federal and state program, provides health insurance to low-income individuals and families. The federal government matches state spending on Medicaid, typically dollar for dollar. Last week, Vice President JD Vance announced the temporary halt of federal matching funds for approximately $250 million Minnesota spent last summer, attributing the decision to concerns about fraudulent activity. As Vance stated, the administration aimed to ensure Minnesota “takes its obligations seriously to be good stewards of the American people’s tax money.”
The move follows President Trump’s recent declaration of a “war on fraud” and the formation of an anti-fraud task force led by Vice President Vance. Minnesota was identified as the first state to be targeted under this initiative, with the administration also implementing a nationwide freeze on new companies seeking Medicare payments for durable medical equipment while investigating potential fraud.
Minnesota officials, however, express surprise and disagreement with the federal government’s actions. Deputy Health Commissioner John Connolly stated that the state has been proactively addressing fraud and had submitted a Corrective Action Plan to the federal government weeks ago, awaiting feedback. “Minnesota has been acting aggressively to combat fraud, and the narrative that additional punitive funding deferrals are necessary to ensure that we are serious about this work does not reflect what we have done,” Connolly explained.
In response, Minnesota has filed a federal lawsuit against the Trump administration, alleging that the withholding of funds is a form of “political punishment.” The lawsuit highlights that Minnesota’s Medicaid fraud rate stands at just 2%, considerably below the national average of 6%.
Health policy experts are voicing concerns about the unprecedented nature of the administration’s actions. Jocelyn Guyer of the consulting firm Manatt Health described the move as “unprecedented, both for the punitive nature and the magnitude of the losses.” She emphasized that addressing fraud is typically done through collaborative partnerships between the federal government and states, rather than through punitive measures.
The potential consequences of the funding halt are significant. Connolly warned that the deferral could create cash flow problems, potentially jeopardizing services for vulnerable populations and destabilizing care for over a million Minnesotans, half of whom are children. The Autism Society of Minnesota’s executive director, Ellie Wilson, expressed the fears of Medicaid beneficiaries, noting that service disruptions have already led to dire consequences for some individuals, including cases of death and homelessness.
The administration’s actions are occurring against a backdrop of increased scrutiny of social services programs in Minnesota. Conservatives have recently highlighted a fraud scheme within the state’s social services system, drawing the attention of Trump and his aides. The Centers for Medicare & Medicaid Services Administrator, Dr. Mehmet Oz, stated that fraudulent activity is “becoming a major source of fraudulent activity” across various programs.
The lawsuit filed by Minnesota argues that the state is being unfairly targeted and that the administration’s actions are not based on legitimate concerns about fraud levels. The state contends that it has demonstrated a commitment to combating fraud and is adhering to all federal requirements. The outcome of the lawsuit remains uncertain, but it could have significant implications for the future of Medicaid funding and the relationship between the federal government and states in administering the program.
As of , a spokesperson for the Federal Centers for Medicare and Medicaid Services declined to comment on the pending litigation.